A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM)
多发性骨髓瘤
泊马度胺
来那度胺
内科学
医学
临床终点
肿瘤科
达拉图穆马
临床试验
作者
Elisabet E. Manasanch,Sundar Jagannath,Hans C. Lee,Krina K. Patel,Connor Graham,Gregory P. Kaufman,Sheeba K. Thomas,Swaminathan P. Iyer,Sham Mailankody,Neha Korde,Behrang Amini,Pei Lin,Zuzana Berkova,Donna M. Weber,Lei Feng,Nikoletta Lendvai,Michelle A.T. Hildebrandt,Sattva S. Neelapu,Robert Z. Orlowski,Ola Landgren
出处
期刊:Blood [American Society of Hematology] 日期:2019-11-13卷期号:134 (Supplement_1): 3116-3116被引量:30